NVO20260807P41
NVO Aug 7 2026 41.00 Put (NVO260807P00041000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.